Evaluating the HER-2 status of breast cancer using mammography radiomics features

被引:39
|
作者
Zhou, Jing [1 ,2 ,4 ]
Tan, Hongna [1 ,2 ]
Bai, Yan [1 ,2 ]
Li, Jie [3 ]
Lu, Qing [1 ,2 ]
Chen, Rushi [1 ,2 ]
Zhang, Menghuan [1 ,2 ]
Feng, Qin [1 ,2 ]
Wang, Meiyun [1 ,2 ]
机构
[1] Henan Prov Peoples Hosp, Dept Radiol, 7 Rd,Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China
[2] Imaging Diag Neurol Dis & Res Lab Henan Prov, Zhengzhou, Henan, Peoples R China
[3] Huiying Med Technol Inc, Beijing, Peoples R China
[4] Mudanjiang Med Univ, Med Imaging Sch, Mudanjiang 157011, Heilongjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Breast cancer; HER-2; Radiomics; Mammography; THERAPY;
D O I
10.1016/j.ejrad.2019.108718
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The aim of our study was to evaluate the HER-2 status in breast cancer patients using mammography (MG) radiomics features. Methods: A total of 306 Chinese female patients with invasive ductal carcinoma of no special type (IDC-NST) enrolled from January 2013 to July 2018 were divided into a training set (n= 244) and a testing set (n= 62). One hundred and eighty-six radiomics features were extracted from digital MG images based on the training set. The least absolute shrinkage and selection operator (LASSO) method was used to select the optimal predictive features for HER-2 status from the training set. Both support vector machine (SVM) and logistic regression models were employed based on the selected features. The area under the receiver operating characteristic (ROC) curves (AUCs) of the training set and testing set were used to evaluate the predictive performance of the models. Results: Compared with the SVM model, the performance of the logistic regression model using a combination of cranial caudal (CC) and mediolateral oblique (MLO) MG views was optimal. In the training set, the sensitivity, specificity, accuracy and area under the curve (AUC) values of the logistic regression model for evaluating HER-2 status based on quantitative radiomics features were 87.29%, 58.73%, 80.00% and 0.846 (95% confidence interval (CI), 0.800-0.887), respectively, and in the testing set, the values were 73.91%, 68.75%, 77.00% and 0.787 (95% CI, 0.673-0.885), respectively. Conclusions: Radiomics features could be an efficient tool for the preoperative evaluation of HER-2 status in patients with breast cancer.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Radiomics Nomogram Based on Radiomics Score from Multiregional Diffusion-Weighted MRI and Clinical Factors for Evaluating HER-2 2+ Status of Breast Cancer
    Li, Chunli
    Yin, Jiandong
    DIAGNOSTICS, 2021, 11 (08)
  • [2] Revolutionizing HER-2 assessment: multidimensional radiomics in breast cancer diagnosis
    Xie, Hui
    Tan, Tao
    Li, Qing
    Li, Tao
    BMC CANCER, 2025, 25 (01)
  • [3] Predicting Breast Cancer Risk Using Radiomics Features of Mammography Images
    Suzuki, Yusuke
    Hanaoka, Shouhei
    Tanabe, Masahiko
    Yoshikawa, Takeharu
    Seto, Yasuyuki
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (11):
  • [4] Assessment of HER-2 status in invasive breast cancer in Brazil
    Arrua Arias, Victor Eduardo
    Gobbi, Helenice
    Ioshii, Sergio Ossamu
    Scapulatempo, Cristovam
    da Paz, Alexandre Rolim
    da Silva, Vinicius Duval
    Uchoa, Diego
    Zettler, Claudio
    Soares, Fernando Augusto
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (07): : 566 - 574
  • [5] Her-2 status in breast cancer patients with orbital metastases
    Albrecht, S.
    Zilli, T.
    Popowski, Y.
    Balmer, Majno S.
    Weber, D. C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 172 - 172
  • [6] HER-2 Status May Change in Recurrent Breast Cancer
    Arnaout, K.
    Khalife, M.
    Younes, M.
    Hanbali, A.
    CANCER RESEARCH, 2009, 69 (24) : 802S - 802S
  • [7] The significance of histological determination of HER-2 status in breast cancer
    Walker, RA
    BREAST, 2000, 9 (03): : 130 - 133
  • [8] Utility of Serum HER-2/ neu in Prediction of Tissue HER-2 /neu Status of Primary Breast Cancer
    Mokhtari, Maral
    Khosravi, Mohammad Hadi
    MIDDLE EAST JOURNAL OF CANCER, 2021, 12 (04) : 483 - 490
  • [9] MRI features of breast cancer: a correlation study with HER-2 receptor
    Agrawal, G.
    Chen, J. H.
    Baek, H. M.
    Hsiang, D.
    Mehta, R. S.
    Nalcioglu, O.
    Su, M. -Y.
    ANNALS OF ONCOLOGY, 2007, 18 (11) : 1903 - 1904
  • [10] Comparative assays for the HER-2/neu oncogene status in breast cancer
    Vera-Román, JM
    Rubio-Martínez, LA
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2004, 128 (06) : 627 - 633